New combo pill may lower cholesterol better than statins alone

NCT ID NCT07445542

Completed Disease control Sponsor: JW Pharmaceutical Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at nearly 7,000 adults with high cholesterol who switched from taking a statin alone to a combination pill containing Pitavastatin and Ezetimibe. The main goal was to see how much their LDL (bad) cholesterol dropped after 24 weeks. The study was observational, meaning doctors decided on the switch, and no comparison group was used.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pitavastatin/Ezetimibe combination pill
What this could lead to: If successful, this could confirm that switching to a combination pill helps lower cholesterol more effectively than statins alone.
What could go wrong: This is an observational study, not a controlled trial, so results may be less reliable. It also does not test long-term heart health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyslipidemias Hypercholesterolemia hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERCHOLESTEROLEMIA

Contacts and locations

Locations

Seoul Metropolitan Government Seoul National University Boramae Medical Center

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.